United States· US:51662-1630_39ae5dd3-dcaa-d40f-e063-6294a90a78af

PROCAINAMIDE HYDROCHLORIDE

A procainamide product containing procainamide hydrochloride, registered in United States by HF Acquisition Co LLC, DBA HealthFirst. The same ATC class is registered in 5 of our 19 countries.

ATC C01BA02Orange BookUS label

Checked against FDA National Drug Code directory (United States) on September 12, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about procainamide hydrochlorideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Procainamide is registered in 5 of 19 countries.

Countries holding a registration under ATC C01BA02 (procainamide), each read from that country’s own register.

This record: United States, from FDA National Drug Code directory (United States)
2 of them publish a price we can compare per daily dose

Search procainamide products by name

Procainamide · ATC C01BA02

5 / 19 countries

Canada
Finlandprice
Japan
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)

Active substance: PROCAINAMIDE HYDROCHLORIDE
Manufacturer: HF Acquisition Co LLC, DBA HealthFirst
Country: United States (US)
ATC code: C01BA02
ATC class: Procainamide
Defined daily dose: 3 g, O
Reimbursed: Not published by this register
Source register: FDA National Drug Code directory (United States)
Last checked: September 12, 2026

Packs & prices · 1

ndc11
5166216303
5 POUCH in 1 CASE (51662-1630-3) / 1 BOX in 1 POUCH (51662-1630-2) / 1 SYRINGE in 1 BOX / 10 mL in 1 SYRINGE (51662-1630-1)

Regulatory notes

UNII (FDA substance ID)

SI4064O0LX

PROCAINAMIDE HYDROCHLORIDE

RxCUI 155056

Orange Book

A088636

DailyMed SPL labels

1 version tracked

Interactions

236 interactions on record for procainamide.

Graded by severity as the source publishes them — 138 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check procainamide against other medicines How interaction checks work

Procainamide · interactions on record

236 records

138 severe
85 moderate
8 minor
4 info

Most severe, free to view

PapaverineA03AD01severe
CisaprideA03FA02severe
OndansetronA04AA01severe
GranisetronA04AA02severe

1 more interaction with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Procainamide in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All procainamide products

Authorised across Europe · EMA

The same active substance is authorised in 1 EEA country. Names it is sold under:

Spain · Biocoryl

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/e7d5b0e3-c9cb-4afa-b7a6-88f17545fea4
GET /v1/drugs/e7d5b0e3-c9cb-4afa-b7a6-88f17545fea4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unii": {
    "unii": "SI4064O0LX",
    "rxcui": "155056",
    "inchikey": "ABTXGJFUQRCPNH-UHFFFAOYSA-N",
    "display_name": "PROCAINAMIDE HYDROCHLORIDE",
    "substance_type": "chemical",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "INTRAMUSCULAR; INTRAVENOUS",
  "livertox": {
    "summary": null,
    "livertox_id": null,
    "hepatotoxicity_score": 3
  },
  "spl_meta": {
    "17e47845-daad-434c-a784-6d3875b0d704": {
      "match": "brand_token",
      "title": "PROCAINAMIDE HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.]",
      "spl_version": "25",
      "published_date": "2026-02-11"
    }
  },
  "productid": "51662-1630_39ae5dd3-dcaa-d40f-e063-6294a90a78af",
  "productndc": "51662-1630",
  "dosage_form": "INJECTION",
  "orange_book": {
    "appl_no": "088636",
    "products": [
      {
        "rs": false,
        "rld": false,
        "te_code": "AP",
        "strength": "100MG/ML",
        "product_no": "001",
        "approval_date": "Jul 31, 1984"
      }
    ],
    "appl_type": "A"
  },
  "dea_schedule": null,
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "PROCAINAMIDE HYDROCHLORIDE",
  "proprietary_name": "PROCAINAMIDE HYDROCHLORIDE",
  "active_ingred_unit": "mg/mL",
  "application_number": "ANDA088636",
  "marketing_category": "ANDA",
  "nonproprietary_name": "PROCAINAMIDE HYDROCHLORIDE",
  "start_marketing_date": "20230623",
  "active_numerator_strength": "100"
}

API reference MCP server Plans

See everything about procainamide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console